Cardiovascular disease, heart failure and COVID-19.
Identifieur interne : 000242 ( Main/Curation ); précédent : 000241; suivant : 000243Cardiovascular disease, heart failure and COVID-19.
Auteurs : Luca Faconti [Royaume-Uni] ; Philip J. Chowienczyk [Royaume-Uni] ; Ajay M. Shah [Royaume-Uni]Source :
- Journal of the renin-angiotensin-aldosterone system : JRAAS [ 1752-8976 ]
Descripteurs français
- KwdFr :
- Betacoronavirus (physiologie), Défaillance cardiaque (complications), Défaillance cardiaque (virologie), Facteurs de risque (MeSH), Hospitalisation (MeSH), Humains (MeSH), Infections à coronavirus (complications), Infections à coronavirus (virologie), Maladies cardiovasculaires (complications), Maladies cardiovasculaires (virologie), Pandémies (MeSH), Peptidyl-Dipeptidase A (métabolisme), Pneumopathie virale (complications), Pneumopathie virale (virologie).
- MESH :
- métabolisme : Défaillance cardiaque, Infections à coronavirus, Maladies cardiovasculaires, Peptidyl-Dipeptidase A, Pneumopathie virale.
- physiologie : Betacoronavirus.
- virologie : Défaillance cardiaque, Infections à coronavirus, Maladies cardiovasculaires, Pneumopathie virale.
- Facteurs de risque, Hospitalisation, Humains, Pandémies.
English descriptors
- KwdEn :
- Betacoronavirus (physiology), Cardiovascular Diseases (complications), Cardiovascular Diseases (virology), Coronavirus Infections (complications), Coronavirus Infections (virology), Heart Failure (complications), Heart Failure (virology), Hospitalization (MeSH), Humans (MeSH), Pandemics (MeSH), Peptidyl-Dipeptidase A (metabolism), Pneumonia, Viral (complications), Pneumonia, Viral (virology), Risk Factors (MeSH).
- MESH :
- chemical , metabolism : Peptidyl-Dipeptidase A.
- complications : Cardiovascular Diseases, Coronavirus Infections, Heart Failure, Pneumonia, Viral.
- physiology : Betacoronavirus.
- virology : Cardiovascular Diseases, Coronavirus Infections, Heart Failure, Pneumonia, Viral.
- Hospitalization, Humans, Pandemics, Risk Factors.
DOI: 10.1177/1470320320926903
PubMed: 32434431
PubMed Central: PMC7243040
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000242
Links to Exploration step
pubmed:32434431Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cardiovascular disease, heart failure and COVID-19.</title>
<author><name sortKey="Faconti, Luca" sort="Faconti, Luca" uniqKey="Faconti L" first="Luca" last="Faconti">Luca Faconti</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Cardiovascular Medicine and Sciences, King's College London, Department of Clinical Pharmacology, St Thomas' Hospital, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Cardiovascular Medicine and Sciences, King's College London, Department of Clinical Pharmacology, St Thomas' Hospital</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Chowienczyk, Philip J" sort="Chowienczyk, Philip J" uniqKey="Chowienczyk P" first="Philip J" last="Chowienczyk">Philip J. Chowienczyk</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Cardiovascular Medicine and Sciences, King's College London, Department of Clinical Pharmacology, St Thomas' Hospital, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Cardiovascular Medicine and Sciences, King's College London, Department of Clinical Pharmacology, St Thomas' Hospital</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Research Excellence, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Research Excellence</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Shah, Ajay M" sort="Shah, Ajay M" uniqKey="Shah A" first="Ajay M" last="Shah">Ajay M. Shah</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Research Excellence, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Research Excellence</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020 Apr-Jun</date>
<idno type="RBID">pubmed:32434431</idno>
<idno type="pmid">32434431</idno>
<idno type="doi">10.1177/1470320320926903</idno>
<idno type="pmc">PMC7243040</idno>
<idno type="wicri:Area/Main/Corpus">000242</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000242</idno>
<idno type="wicri:Area/Main/Curation">000242</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000242</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Cardiovascular disease, heart failure and COVID-19.</title>
<author><name sortKey="Faconti, Luca" sort="Faconti, Luca" uniqKey="Faconti L" first="Luca" last="Faconti">Luca Faconti</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Cardiovascular Medicine and Sciences, King's College London, Department of Clinical Pharmacology, St Thomas' Hospital, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Cardiovascular Medicine and Sciences, King's College London, Department of Clinical Pharmacology, St Thomas' Hospital</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Chowienczyk, Philip J" sort="Chowienczyk, Philip J" uniqKey="Chowienczyk P" first="Philip J" last="Chowienczyk">Philip J. Chowienczyk</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Cardiovascular Medicine and Sciences, King's College London, Department of Clinical Pharmacology, St Thomas' Hospital, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Cardiovascular Medicine and Sciences, King's College London, Department of Clinical Pharmacology, St Thomas' Hospital</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Research Excellence, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Research Excellence</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Shah, Ajay M" sort="Shah, Ajay M" uniqKey="Shah A" first="Ajay M" last="Shah">Ajay M. Shah</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Research Excellence, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Research Excellence</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of the renin-angiotensin-aldosterone system : JRAAS</title>
<idno type="eISSN">1752-8976</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (physiology)</term>
<term>Cardiovascular Diseases (complications)</term>
<term>Cardiovascular Diseases (virology)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (virology)</term>
<term>Heart Failure (complications)</term>
<term>Heart Failure (virology)</term>
<term>Hospitalization (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Peptidyl-Dipeptidase A (metabolism)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (virology)</term>
<term>Risk Factors (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Betacoronavirus (physiologie)</term>
<term>Défaillance cardiaque (complications)</term>
<term>Défaillance cardiaque (virologie)</term>
<term>Facteurs de risque (MeSH)</term>
<term>Hospitalisation (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (complications)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Maladies cardiovasculaires (complications)</term>
<term>Maladies cardiovasculaires (virologie)</term>
<term>Pandémies (MeSH)</term>
<term>Peptidyl-Dipeptidase A (métabolisme)</term>
<term>Pneumopathie virale (complications)</term>
<term>Pneumopathie virale (virologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Peptidyl-Dipeptidase A</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Cardiovascular Diseases</term>
<term>Coronavirus Infections</term>
<term>Heart Failure</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Défaillance cardiaque</term>
<term>Infections à coronavirus</term>
<term>Maladies cardiovasculaires</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Défaillance cardiaque</term>
<term>Infections à coronavirus</term>
<term>Maladies cardiovasculaires</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Cardiovascular Diseases</term>
<term>Coronavirus Infections</term>
<term>Heart Failure</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Hospitalization</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Facteurs de risque</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Pandémies</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32434431</PMID>
<DateCompleted><Year>2020</Year>
<Month>06</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>06</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1752-8976</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>21</Volume>
<Issue>2</Issue>
<PubDate><MedlineDate>2020 Apr-Jun</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of the renin-angiotensin-aldosterone system : JRAAS</Title>
<ISOAbbreviation>J Renin Angiotensin Aldosterone Syst</ISOAbbreviation>
</Journal>
<ArticleTitle>Cardiovascular disease, heart failure and COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>1470320320926903</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1177/1470320320926903</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Faconti</LastName>
<ForeName>Luca</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>School of Cardiovascular Medicine and Sciences, King's College London, Department of Clinical Pharmacology, St Thomas' Hospital, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chowienczyk</LastName>
<ForeName>Philip J</ForeName>
<Initials>PJ</Initials>
<AffiliationInfo><Affiliation>School of Cardiovascular Medicine and Sciences, King's College London, Department of Clinical Pharmacology, St Thomas' Hospital, UK.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Research Excellence, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Shah</LastName>
<ForeName>Ajay M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo><Affiliation>School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Research Excellence, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>J Renin Angiotensin Aldosterone Syst</MedlineTA>
<NlmUniqueID>100971636</NlmUniqueID>
<ISSNLinking>1470-3203</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>EC 3.4.15.1</RegistryNumber>
<NameOfSubstance UI="D007703">Peptidyl-Dipeptidase A</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.17.-</RegistryNumber>
<NameOfSubstance UI="C413524">angiotensin converting enzyme 2</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007703" MajorTopicYN="N">Peptidyl-Dipeptidase A</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>6</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32434431</ArticleId>
<ArticleId IdType="doi">10.1177/1470320320926903</ArticleId>
<ArticleId IdType="pmc">PMC7243040</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Lancet. 2020 Feb 22;395(10224):565-574</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32007145</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Med. 2004 May 19;2:19</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15151696</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32171076</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hypertension. 2004 May;43(5):970-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15007027</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Intensive Care Med. 2020 May;46(5):846-848</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32125452</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2013 Oct 23;310(16):1711-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24150467</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8258-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12829792</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Feb 24;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Circulation. 2003 Oct 14;108(15):1798-803</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14504188</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Circulation. 2005 May 24;111(20):2605-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15897343</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tex Heart Inst J. 2004;31(1):4-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15061620</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2005 Aug;11(8):875-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16007097</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Hypertens. 2020 May;38(5):781-782</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32195824</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antioxid Redox Signal. 2013 Oct 1;19(10):1095-109</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22429089</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Feb 7;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32031570</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32064853</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2013 Feb 9;381(9865):496-505</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23332146</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CardioCovidV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000242 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 000242 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CardioCovidV1 |flux= Main |étape= Curation |type= RBID |clé= pubmed:32434431 |texte= Cardiovascular disease, heart failure and COVID-19. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:32434431" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \ | NlmPubMed2Wicri -a CardioCovidV1
![]() | This area was generated with Dilib version V0.6.35. | ![]() |